{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:31:48Z","timestamp":1766493108231},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0291","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T22:07:03Z","timestamp":1599084423000},"page":"111-117","source":"Crossref","is-referenced-by-count":12,"title":["Insulin resistant diabetes mellitus in SHORT syndrome: case report and literature review"],"prefix":"10.1507","volume":"68","author":[{"given":"Yohei","family":"Masunaga","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Fukami","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"Kagami","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotomo","family":"Saitsu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Innes AM, Dyment DA (2014) SHORT Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, et al. (ed) GeneReviews. University of Washington, Seattle, WA: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1116\/."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Avila M, Dyment DA, Sagen JV, St-Onge J, Moog U, et al. (2016) Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and management. Clin Genet 89: 501\u2013506.","DOI":"10.1111\/cge.12688"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Thauvin-Robinet C, Auclair M, Duplomb L, Caron-Debarle M, Avila M, et al. (2013) PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet 93: 141\u2013149.","DOI":"10.1016\/j.ajhg.2013.05.019"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Chudasama KK, Winnay J, Johansson S, Claudi T, K\u00f6nig R, et al. (2013) SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Am J Hum Genet 93: 150\u2013157.","DOI":"10.1016\/j.ajhg.2013.05.023"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Dyment DA, Smith AC, Alcantara D, Schwartzentruber JA, Basel-Vanagaite L, et al. (2013) Mutations in PIK3R1 cause SHORT syndrome. Am J Hum Genet 93: 158\u2013166.","DOI":"10.1016\/j.ajhg.2013.06.005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wakeling EL, Brioude F, Lokulo-Sodipe O, O\u2019Connell SM, Salem J, et al. (2017) Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol 13: 105\u2013124.","DOI":"10.1038\/nrendo.2016.138"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Verge CF, Donaghue KC, Williams PF, Cowell CT, Silink M (1994) Insulin-resistant diabetes during growth hormone therapy in a child with SHORT syndrome. Acta Paediatr 83: 786\u2013788.","DOI":"10.1111\/j.1651-2227.1994.tb13142.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Silva S, Maia J, Claessens AL, Beunen G, Pan H (2012) Growth references for Brazilian children and adolescents: healthy growth in Cariri study. Ann Hum Biol 39: 11\u201318.","DOI":"10.3109\/03014460.2011.632646"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Yamazawa K, Kagami M, Nagai T, Kondoh T, Onigata K, et al. (2008) Molecular and clinical findings and their correlations in Silver-Russell syndrome: implications for a positive role of IGF2 in growth determination and differential imprinting regulation of the IGF2-H19 domain in bodies and placentas. J Mol Med 86: 1171\u20131181.","DOI":"10.1007\/s00109-008-0377-4"},{"key":"10","doi-asserted-by":"crossref","first-page":"e88766","DOI":"10.1172\/jci.insight.88766","volume":"1","author":"I Huang-Doran","year":"2016","unstructured":"11 Huang-Doran I, Tomlinson P, Payne F, Gast A, Sleigh A, et al. (2016) Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations. JCI Insight 1: e88766.","journal-title":"JCI Insight","ISSN":"http:\/\/id.crossref.org\/issn\/2379-3708","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 B\u00e1rcena C, Quesada V, De Sandre-Giovannoli A, Puente DA, Fern\u00e1ndez-Toral J, et al. (2014) Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome. BMC Med Genet 15: 51.","DOI":"10.1186\/1471-2350-15-51"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13 Hamaguchi T, Hirota Y, Takeuchi T, Nakagawa Y, Matsuoka A, et al. (2018) Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor. J Diabetes Investig 9: 1224\u20131227.","DOI":"10.1111\/jdi.12825"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14 Kagami M, Yanagisawa A, Ota M, Matsuoka K, Nakamura A, et al. (2019) Temple syndrome in a patient with variably methylated CpGs at the primary MEG3\/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR. Clin Epigenetics 11: 42.","DOI":"10.1186\/s13148-019-0640-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15 Yamoto K, Saitsu H, Nakagawa N, Nakajima H, Hasegawa T, et al. (2017) <i>De novo<\/i> IGF2 mutation on the paternal allele in a patient with Silver-Russell syndrome and ectrodactyly. Hum Mutat 38: 953\u2013958.","DOI":"10.1002\/humu.23253"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16 Richards S, Aziz N, Bale S, Bick D, Das S, et al. (2015) ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17: 405\u2013424.","DOI":"10.1038\/gim.2015.30"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 Kelsey MM, Zeitler PS (2016) Insulin resistance of puberty. Curr Diab Rep 16: 64.","DOI":"10.1007\/s11892-016-0751-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Urakami T (2019) Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes Metab Syndr Obes 12: 1047\u20131056.","DOI":"10.2147\/DMSO.S179793"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Yorifuji T, Higuchi S, Hosokawa Y, Kawakita R (2018) Chromosome 6q24-related diabetes mellitus. Clin Pediatr Endocrinol 27: 59\u201365.","DOI":"10.1297\/cpe.27.59"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Semple RK, Williams RM, Dunger DB (2010) What is the best management strategy for patients with severe insulin resistance? Clin Endocrinol 73: 286\u2013290.","DOI":"10.1111\/j.1365-2265.2010.03810.x"},{"key":"20","unstructured":"21 Harouch SB, Klar A, Zaccai TCF (2018) INSR-related severe syndromic insulin resistance. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, et al. (ed) GeneReviews. University of Washington, Seattle, WA: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK476444\/."},{"key":"21","doi-asserted-by":"crossref","unstructured":"22 Sha S, Devineni D, Ghosh A, Polidori D, Chien S, et al. (2011) Canagliflozin, a novel inhibitor of sodium glucose cotransporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects. Diabetes Obes Metab 13: 669\u2013672.","DOI":"10.1111\/j.1463-1326.2011.01406.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, et al. (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study. J Allergy Clin Immun 138: 210\u2013218.","DOI":"10.1016\/j.jaci.2016.03.022"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Domen\u00e9 HM, Fierro-Carri\u00f3n G (2018) Genetic disorders of GH action pathway. Growth Horm IGF Res 38: 19\u201323.","DOI":"10.1016\/j.ghir.2017.12.004"},{"key":"24","unstructured":"25 Hakuno F, Takahashi S (2018) IGF1 receptor signaling pathways. J Mol Endocrinol 61: T69\u2013T86."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/1\/68_EJ20-0291\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:27:16Z","timestamp":1611977236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/1\/68_EJ20-0291\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0291","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}